Predictive factors for treatment responses to baricitinib in severe alopecia areata: A retrospective, multivariate analysis of 70 cases from a single centerMoyuka Wada‐Irimada, Yoshihide Asano, Takehiro Takahashi et al.|The Journal of Dermatology|2025Cited by 15
Ritlecitinib in Alopecia Areata: A 24‐Week Real‐World Experience Contrasting <scp>JAK</scp> Inhibitor‐Naïve and <scp>JAK</scp> Inhibitor‐Experienced PatientsToshiki Okazaki, Yoshihide Asano, Takehiro Takahashi et al.|The Journal of Dermatology|2025Cited by 5
Disseminated maculopapular drug eruption caused by ritlecitinib in a patient with alopecia areataToshiki Okazaki, Yoshihide Asano, Takehiro Takahashi et al.|European Journal of Dermatology|2025Cited by 2
Two cases of multicentric reticulohistiocytosis with differing onset of cutaneous and joint symptomsToshiki Okazaki, Yoshihide Asano, Toshiya Takahashi et al.|European Journal of Dermatology|2025Cited by 1
A case of plexiform schwannoma arising in a patient with neurofibromatosis type 2M. Ueki, Yoshihide Asano, Toshiki Okazaki et al.|European Journal of Dermatology|2025Cited by 0